BioLife Solutions Inc (BLFS)

1.99
0.01 0.50
NASDAQ : Health Care
Prev Close 2.00
Open 2.00
Day Low/High 1.91 / 2.01
52 Wk Low/High 1.46 / 4.18
Volume 34.22K
Avg Volume 49.80K
Exchange NASDAQ
Shares Outstanding 12.88M
Market Cap 25.76M
EPS -0.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

BioLife Solutions Restructures Biologistex™ Joint Venture

BioLife Solutions Restructures Biologistex™ Joint Venture

Consolidation of Cold Chain Technologies Enables External Investment in evo™ Smart Shipper and biologistex SaaS Opportunity

BioLife Solutions And Brooks Life Sciences Partner On Study Of Best Practices For Shipping And Storing Time And Temperature Sensitive Biologic Materials

BioLife Solutions And Brooks Life Sciences Partner On Study Of Best Practices For Shipping And Storing Time And Temperature Sensitive Biologic Materials

CryoStor® Cell Freeze Media, evo™ Smart Shipper and BioStore™ III Cryo LN2 Storage System Enable Improved Cell Viability and Faster Cell Recovery

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks that are within range of triggering big breakouts.

BioLife Solutions' CryoStor® Integrated In Kolon Group's Cell-Mediated Gene Therapy For Osteoarthritis

BioLife Solutions' CryoStor® Integrated In Kolon Group's Cell-Mediated Gene Therapy For Osteoarthritis

Approval to Market Invossa™ Filed with Korean Ministry of Food and Drug Safety

BioLife Solutions (BLFS) Is Strong On High Volume Today

BioLife Solutions (BLFS) Is Strong On High Volume Today

Trade-Ideas LLC identified BioLife Solutions (BLFS) as a strong on high relative volume candidate

BioLife Solutions (BLFS) Weak On High Volume

BioLife Solutions (BLFS) Weak On High Volume

Trade-Ideas LLC identified BioLife Solutions (BLFS) as a weak on high relative volume candidate

New Journal Articles Cite Expanded Use Of BioLife Solutions Products In Clinical Cell Therapy Applications

New Journal Articles Cite Expanded Use Of BioLife Solutions Products In Clinical Cell Therapy Applications

CryoStor® Clinical Grade Cell Freeze Media Enabling Development of Novel Regenerative Medicine Therapies for Large Disease States

BioLife Solutions Announces 2015 Biopreservation Media Revenue Growth Of 30%

BioLife Solutions Announces 2015 Biopreservation Media Revenue Growth Of 30%

Expanded Biopreservation Media Product Adoption, SaaS Cold Chain App Deployment, Planned Entry into Organ Preservation Solutions Market Set Stage for 2016 Growth

BioLife Solutions Distributor STEMCELL Technologies Will Test The Evo™ Smart Shipper And Cloud Based Biologistex™ Cold Chain Management App

BioLife Solutions Distributor STEMCELL Technologies Will Test The Evo™ Smart Shipper And Cloud Based Biologistex™ Cold Chain Management App

evo Smart Shippers Could be Used to Transport a Variety of Temperature Sensitive Products for Research in Areas such as Cellular Therapies, Blood Cancers, and Solid Tumors

BioLife Solutions Customer Capricor Therapeutics Provides Update On Heart Failure Cell Therapy Safety Data At American Heart Association Scientific Sessions

BioLife Solutions Customer Capricor Therapeutics Provides Update On Heart Failure Cell Therapy Safety Data At American Heart Association Scientific Sessions

Clinical Grade CryoStor® Cryopreservation Media Used to Freeze and Administer Cells to Patients in DYNAMIC Clinical Trial

Kiadis Pharma Utilizes BioLife Solutions HypoThermosol® To Improve Viability And Shelf Life Of Donor Leukocytes In Clinical Trial Of ATIR101™ T Cell Therapy For Blood Cancers

Kiadis Pharma Utilizes BioLife Solutions HypoThermosol® To Improve Viability And Shelf Life Of Donor Leukocytes In Clinical Trial Of ATIR101™ T Cell Therapy For Blood Cancers

ATIR101™ Offers Potential Curative Stem Cell Transplant Option for the 35% of Eligible Cancer Patients Who Do Not Find a Matching Donor in Time

BioLife Solutions Reports Record Revenue And Provides Operations Update For Q3 2015

BioLife Solutions Reports Record Revenue And Provides Operations Update For Q3 2015

33% Biopreservation Media Revenue Growth over Q3 2014